Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Yves Cahn

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, David Sibon, et al.
Journal of Hematology & Oncology|September 4, 2016
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTFrancesco Saraceni, Myriam Labopin, Norbert-Claude Gorin, et al.
Bone Marrow Transplantation|May 18, 2023
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvementRohtesh S Mehta, Haris Ali, Yang Dai, et al.
American Journal of Infection Control|July 28, 2009
Influence of internal and outdoor factors on filamentous fungal flora in hematology wardsMarie-Pierre Brenier-Pinchart, Bernadette Lebeau, Jean-Louis Quesada, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
American Journal of Hematology|May 27, 2015
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT)Xavier Poiré, Myriam Labopin, Jan J Cornelissen, et al.
Blood|May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyJean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
American Journal of Hematology|July 8, 2018
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow TransplantationMaria H Gilleece, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL studyAline Tanguy-Schmidt, Philippe Rousselot, Yves Chalandon, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationCharalampia Kyriakou, Carmen Canals, David Sibon, et al.
Journal of Hematology & Oncology|September 4, 2016
Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMTFrancesco Saraceni, Myriam Labopin, Norbert-Claude Gorin, et al.
Bone Marrow Transplantation|May 18, 2023
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvementRohtesh S Mehta, Haris Ali, Yang Dai, et al.
American Journal of Infection Control|July 28, 2009
Influence of internal and outdoor factors on filamentous fungal flora in hematology wardsMarie-Pierre Brenier-Pinchart, Bernadette Lebeau, Jean-Louis Quesada, et al.
Oncotarget|December 30, 2017
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromesMathieu Meunier, Sarah Ancelet, Christine Lefebvre, et al.
American Journal of Hematology|May 27, 2015
Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (ALWP) of the European group of blood and marrow transplantation (EBMT)Xavier Poiré, Myriam Labopin, Jan J Cornelissen, et al.
Blood|May 10, 2005
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective studyJean-Yves Cahn, John P Klein, Stephanie J Lee, et al.
American Journal of Hematology|July 8, 2018
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow TransplantationMaria H Gilleece, Myriam Labopin, Ibrahim Yakoub-Agha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2012
Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL studyAline Tanguy-Schmidt, Philippe Rousselot, Yves Chalandon, et al.
Pageof 17